BIND Therapeutics isu00a0a clinicalstage nanomedicine platform company developing Accurins a class of highly selective targeted therapeutics
Made For
BIND Therapeutics isu00a0a clinicalstage nanomedicine platform company developing Accurins a class of highly selective targeted therapeutics
Ashpool has identified 2 products used by BIND Therapeutics
Ashpool has identified the primary mail recipient on this domain as Mimecast
Format | Success Rate |
firstlast@bindtherapeutics.com |
|
flast@bindtherapeutics.com |
|
firstl@bindtherapeutics.com |
|
first@bindtherapeutics.com |
|